Gene mutation ‘hotspots’ linked to better breast cancer outcomes

Using a database of human tumor genomic data, researchers discovered that mutation hotspots known as kataegis are a positive marker in breast cancer — patients with kataegis have less invasive tumors and better prognoses. The study also suggests kataegis status could help doctors determine treatment options that might work best for patients with the mutation pattern.